Posaconazole Oral Suspension bulk supplier for pharma manufacturers

Posaconazole Oral Suspension 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Oral Suspension

Available Strengths: 40 mg/mL

Reference Brands: Noxafil(US & EU)

Posaconazole oral suspension inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane integrity. It offers broad-spectrum antifungal activity, improved absorption, and versatility for prophylaxis and treatment of invasive fungal infections. Benefits include effective coverage, convenient dosing, and high bioavailability for managing severe fungal diseases.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Posaconazole oral suspension is approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil suspension is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continual safety monitoring. For expert support with dossiers, regulatory submissions, and compliance, visit PharmaTradz. We help ensure smooth market entry and adherence to European and American standards, enabling effective management of fungal infections with posaconazole oral suspension.

Posaconazole Oral Suspension — third party manufacturing & bulk supply

Posaconazole Oral Suspension 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Posaconazole Oral Suspension is supplied as Oral Suspension — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Posaconazole Oral Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Posaconazole Oral Suspension →

Back to Listing

Frequently Asked Questions

Posaconazole is used to prevent and treat serious fungal infections in high-risk patients, especially those with weakened immune systems such as individuals with hematologic cancers or transplant recipients. It is effective against invasive aspergillosis, mucormycosis, and resistant Candida infections, and is often used when other antifungals are not tolerated or have failed.

Posaconazole contains the active triazole antifungal compound posaconazole. The formulation uses specific pharmaceutical excipients designed to enhance absorption in the digestive system and ensure stable systemic exposure.

The main trade name is Noxafil, widely used in the USA, EU, UK, and other international regions.

Noxafil is manufactured by Merck & Co. (MSD). Several GMP-certified global pharmaceutical manufacturers also produce generic posaconazole for different markets.

The generic name is posaconazole.

The primary brand name is Noxafil.

Posaconazole is manufactured in Merck’s regulated facilities in the USA and Europe, along with additional GMP-approved manufacturers that supply generic posaconazole for worldwide distribution.